ID
17938
Description
A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00585533
Link
https://clinicaltrials.gov/show/NCT00585533
Keywords
Versions (1)
- 10/11/16 10/11/16 -
Uploaded on
October 11, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Lung Cancer NCT00585533
Eligibility Lung Cancer NCT00585533
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Pregnancy | Breast Feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
Metastatic malignant neoplasm to brain
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
Prior Chemotherapy Systemic disease
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1514457
- UMLS CUI [1,2]
- C0442893
Description
organ dysfunction Impending | Chemotherapy Patient need for
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0349410
- UMLS CUI [1,2]
- C0332190
- UMLS CUI [2,1]
- C0392920
- UMLS CUI [2,2]
- C0686904
Similar models
Eligibility Lung Cancer NCT00585533
- StudyEvent: Eligibility
C0858307 (UMLS CUI [2])
C3846005 (UMLS CUI [1,2])
C2911577 (UMLS CUI [2,1])
C2826292 (UMLS CUI [2,2])
C0006147 (UMLS CUI [2])
C0442893 (UMLS CUI [1,2])
C0332190 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])